Resaphene Suisse AG

Resaphene Suisse AG is an innovation-driven health-tech company headquartered in Switzerland, with a clear focus on the development and commercialization of advanced therapeutic solutions for tinnitus treatment. Resaphene combines scientifically grounded research with entrepreneurial execution and pursues the objective of setting new standards in tinnitus therapy. The company operates in a rapidly growing and medically underserved market and is positioned as a leading provider of scalable, evidence-based therapeutic approaches in this field. At the core of Resaphene’s activities are: the development of clinically and scientifically substantiated therapy concepts, their international commercialization and scalability, and the establishment of long-term partnerships with medical professionals, distribution partners, and investors. Resaphene addresses patients, healthcare professionals, and strategic partners who value quality, transparency, and long-term therapeutic effectiveness. The company’s ambition is to translate medical innovation into measurable patient outcomes and sustainable economic value. As an employer, Resaphene stands for: an entrepreneurial, performance-driven environment, short decision-making paths with direct access to senior management, and the opportunity to actively contribute to the growth of a market-shaping health-tech company with international reach. Resaphene offers ambitious professionals the opportunity to become part of a company that combines medical innovation with significant global growth potential.